<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>journal-jmsr</PublisherName>
      <JournalTitle>Journal of Medical and Surgical Research</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Vol. XII, n 1</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>June 2025</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>2025</Year>
        <Month>08</Month>
        <Day>31</Day>
      </PubDate>
      <ArticleType>JMSR Gastroenterology</ArticleType>
      <ArticleTitle>Quality of Life Among Crohn’s Disease Patients in Morocco: A Cross-Sectional Study</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1448</FirstPage>
      <LastPage>1458</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Aicha Hanae Ait El</FirstName>
          <LastName>Kounnini</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Zhor</FirstName>
          <LastName>Zeghari</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Jihane</FirstName>
          <LastName>Belayachi</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Redouane</FirstName>
          <LastName>Abouqal</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Fatima Zohra</FirstName>
          <LastName>Ajana</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI>10.46327/msrjg.1.000000000000271</DOI>
      <Abstract>Background: Crohn’s disease is a chronic inflammatory bowel disease characterized by alternating periods of flare-ups and remission, with symptoms that can significantly impair patients’ health-related quality of life. The aim of this study was to evaluate the quality of life of Moroccan patients and to identify factors associated with it. Materials __ampersandsign Methods: Between November 2024 and April 2025, a cross-sectional study was carried out at the Ibn Sina Hospital__ampersandsign#39;s Hepato-Gastroenterology department __doublequotosingC__doublequotosing in Rabat. The SF-12 and SIBDQ scores, as well as the sociodemographic and clinical traits of the patients, were among the data gathered. Results: The mean age of the 159 patients who met the inclusion criteria was 42.4 ---PlusMinusSymbol--- 13.4 years, 38.7% had a high risk of malnutrition, 47.7% had an active or very aggressive illness, and 37.1% were male. 38.3% of the population had no disability in the physical component of the SF-12, 27.9% had severe disability in the mental component, and over half of the population had significantly impaired quality of life based on the SIBDQ score. Female gender, recent hospitalization, disease activity, and risk of malnutrition were all found to be important factors by multivariable analysis. Conclusion: These results emphasize how crucial it is to evaluate patients__ampersandsign#39; quality of life and how Crohn__ampersandsign#39;s disease affects it in order to provide thorough multidisciplinary care.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Crohn's disease, inflammatory bowel disease, Morocco, quality of life, risk of malnutrition, SF-12, SIBDQ.</Keywords>
      <URLs>
        <Abstract>https://www.journal-jmsr.net/ubijournal-v1copy/journals/abstract.php?article_id=15922&amp;title=Quality of Life Among Crohn’s Disease Patients in Morocco: A Cross-Sectional Study</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Na Li , Rui-Hua Shi. Updated review on immune factors in pathogenesis of Crohn’s disease - PMC. 2018 Jan;7;24(1):15?22.&#13;
	Dolinger M, Torres J, Vermeire S. Crohn’s disease. Lancet Lond Engl. 2024 Mar 23;403(10432):1177–91.&#13;
	Walton H, Gros B, Din S. Crohn’s disease. Medicine (Baltimore). 2024 Apr 1;52(4):238–44.&#13;
	Damien Malbos. Crohn’s disease, complex and disabling- ScienceDirect. 2024 Oct;63, Issue 639:44?8.&#13;
	Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology. 2021 Oct;161(4):1118?32.&#13;
	Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet. 2017 Dec;390(10114):2769–78.&#13;
	Hodges P, Kelly P. Inflammatory bowel disease in Africa: what is the current state of knowledge? Int Health. 2020 Mar 4;12(3):222?30.&#13;
	Abid H, Cherkaoui H, Benahsine F, Lamine A, Lahlali M, Chaouche I, et al. Non-invasive monitoring of inflammatory bowel disease using intestinal ultrasound. World J Gastrointest Endosc. 2025 Mar 16;17(3):97016.&#13;
	Varma A, Weinstein J, Seabury J, Rosero S, Wagner E, Zizzi C, et al. Patient-Reported Impact of Symptoms in Crohn’s Disease. Am J Gastroenterol. 2022 Dec 1;117(12):2033–45.&#13;
	Ganz ML, Sugarman R, Wang R, Hansen BB, Hand;aring;kan-Bloch J. The Economic and Health-related Impact of Crohn’s Disease in the United States: Evidence from a Nationally Representative Survey. Inflamm Bowel Dis. 2016 May;22(5):1032?41.&#13;
	Radford SJ, McGing J, Czuber-Dochan W, Moran G. Systematic review: the impact of inflammatory bowel disease-related fatigue on health-related quality of life. Frontline Gastroenterol. 2021;12(1):11–21&#13;
	Chiarini M, Di Simone E, Scafuro C, Auddino F, Fabbri M, Delli Poggi A, et al. Health self-perception in patient with Crohn’s disease: a web survey. Clin Ter. 2017;168(6):e401–5.&#13;
	Azza A E Mahalli , Hana M A Alharthi. Assessment of health-related quality of life of patients with inflammatory bowel diseases in Eastern Province, Saudi Arabia. Journal of Infection and Public Health. 2017 Jan 1;10(1):93?101.&#13;
	Cheifetz AS. Management of Active Crohn Disease. JAMA. 2013 May 22;309(20):2150?8.&#13;
	Fraga M, Godat S, Schoepfer AM, Moradpour D, Nydegger A. Calprotectinefand;eacute;cale?: outil diagnostique dans les maladies inflammatoires chroniques de l’intestin. Rev Med Suisse. 2012 Sept 5;352(30):1669?73.&#13;
	Panaccione R, Colombel JF, Louis E, Peyrin-Biroulet L, Sandborn WJ. Evolving Definitions of Remission in Crohn’s Disease. Inflammatory Bowel Diseases. 2013 Jul;19(8):1645?53.&#13;
	Swaminathan A, Day AS, Sparrow MP, Peyrin-Biroulet L, Siegel CA, Gearry RB. Review article: Measuring disease severity in inflammatory bowel disease - Beyond treat to target. Aliment Pharmacol Ther. 2024 Nov;60(9):1176–99.&#13;
	Daoudim F, Bakass F. A new multidimensional approach to measuring the middle class dynamics: evidence from Morocco. International Journal of Development Issues 2022 Sep 20; 21 (3): 438–457.&#13;
	Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976 Mar;70(3):439?44.&#13;
	Thia K, Faubion WA Jr, Loftus EV Jr, Persson T, Persson A, Sandborn WJ. Short CDAI: Development and validation of a shortened and simplified Crohn’s disease activity index. Inflammatory Bowel Diseases. 2011 Jan 1;17(1):105?11.&#13;
	Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity. Medical Care.1996 Mar;34(3):220.&#13;
	Andrews G. A brief integer scorer for the SF-12: validity of the brief scorer in Australian community and clinic settings. Aust N Z J Public Health. 2002 Dec;26(6):508?10.&#13;
	Ware J, Kosinski M, Keller S. SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales.1998 Jan 1;&#13;
	Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn’s Relapse Prevention Trial. Am J Gastroenterol. 1996 Aug;91(8):1571?8.&#13;
	Haskey N, Peand;ntilde;a-Sand;aacute;nchez JN, Jones JL, Fowler SA. Development of a screening tool to detect nutrition risk in patients with inflammatory bowel disease. Asia Pac J Clin Nutr.2018;27(4):756?62.&#13;
	Gold SL, Raman M. Malnutrition Assessment in Patients with Inflammatory Bowel Disease. Canadian IBD Today. 2023 Apr 11;32?8.&#13;
	Li S, Ney M, Eslamparast T, Vandermeer B, Ismond KP, Kroeker K, and al. Systematic review of nutrition screening and assessment in inflammatory bowel disease. World Journal of Gastroenterology. 2019 Jul 28; 25(28):3823?37.&#13;
	Cao Q, Huang YH, Jiang M, Dai C. The prevalence and risk factors of psychological disorders, malnutrition and quality of life in IBD patients. Scandinavian Journal of Gastroenterology. 2019 Dec 2;54(12):1458?66.&#13;
	Zhang Y, Zhang L, Gao X, Dai C, Huang Y, Wu Y, and al. Impact of malnutrition and sarcopenia on quality of life in patients with inflammatory bowel disease: A multicenter study. J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2663?75.&#13;
	Cioffi I, Imperatore N, Di Vincenzo O, Santarpia L, Rispo A, Marra M, and al. Association between Health-Related Quality of Life and Nutritional Status in Adult Patients with Crohn’s Disease. Nutrients. 2020 Mar;12(3):746.&#13;
	van der Have M, van der Aalst KS, Kaptein AA, Leenders M, Siersema PD, Oldenburg B, and al. Determinants of health-related quality of life in Crohn’s disease: a systematic review and meta-analysis. J Crohns Colitis. 2014 Feb;8(2):93?106.&#13;
	Almadani SB, Adler J, Browning J, Green EH, Helvie K, Rizk RS, et al. Effects of inflammatory bowel disease on students’ adjustment to college. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2014 Dec;12(12):2055-2062.e1.&#13;
	Loly C, Belaiche ,Jacques, and Louis E. Predictors of severe Crohn’s disease. Scandinavian Journal of Gastroenterology. 2008 Jan 1;43(8):948?54.&#13;
	Rigaud D, Cerf M, Angel Alberto L, Sobhani I, Carduner MJ, Mignon M. (Increase of resting energy expenditure during flare-ups in Crohn disease). Gastroenterol Clin Biol. 1993 Jan 1;17(12):932?7.&#13;
	de Dios-Duarte MJ, Arias A, Durantez-Fernand;aacute;ndez C, Niand;ntilde;o Martand;iacute;n V, Olea E, Barba-Pand;eacute;rez Mand;Aacute;, et al. Flare-Ups in Crohn’s Disease: Influence of Stress and the External Locus of Control. Int J Environ Res Public Health. 2022 Oct 12;19(20):13131.&#13;
	de Dios-Duarte MJ, Arias A, Barrand;oacute;n A. Impact of Psychosocial Factors on the Activity of Crohn’s Disease: A Cross-Sectional Analysis of Social Support, Stress, and Flare-Up Incidence. Journal of Clinical Medicine. 2024 Jan;13(11):3086.&#13;
	Ballester Ferrand;eacute; MP, Boscand;aacute;-Watts MM, Mand;iacute;nguez Pand;eacute;rez M. Crohn’s disease. Med Clin (Barc). 2018 July 13;151(1):26?33.&#13;
	Binder HJ. Mechanisms of Diarrhea in Inflammatory Bowel Diseases. Annals of the New York Academy of Sciences. 2009;1165(1):285?93.&#13;
	Anbazhagan AN, Priyamvada ,Shubha, Alrefai ,Waddah A., and Dudeja PK. Pathophysiology of IBD associated diarrhea. Tissue Barriers. 2018 Apr 3;6(2):e1463897.&#13;
	Lichtenstein GR, Yan S, Bala M, Hanauer S. Remission in patients with Crohn’s disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol. 2004 Jan;99(1):91?6.&#13;
	Zhou Y, Ren W, Irvine EJ, Yang D. Assessing health-related quality of life in patients with inflammatory bowel disease in Zhejiang, China. J Clin Nurs. 2010 Jan;19(1?2):79?88.&#13;
	Malarcher CA, Wheaton AG, Liu Y, Greenlund SF, Greenlund SJ, Lu H, and al. Hospitalizations for Crohn’s Disease - United States, 2003-2013. MMWR Morb Mortal Wkly Rep. 2017 Apr 14;66(14):377?81.&#13;
	Bernstein CN, Loftus EV, Ng SC, Lakatos PL, Moum B, Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD). Hospitalisations and surgery in Crohn’s disease. Gut. 2012 Apr;61(4):622?9.&#13;
	Voyvodic LC, Khan NZ, Lam AW, Horn AR, Mont MA, Razi AE. Crohn’s Disease is Associated with Longer In-Hospital Lengths of Stay and Higher Rates of Complications and Costs after Primary Total Hip Arthroplasty. J Arthroplasty. 2021 June;36(6):2110?5.&#13;
	Stjernman H, Tysk C, Almer S, Strand;ouml;m M, Hjortswang H. Unfavourable outcome for women in a study of health-related quality of life in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2011 Aug;23(8):716-22. Available from: https://journals.lww.com/eurojgh/abstract/2011/08000/unfavourable_outcome_for_women_in_a_study_of.6.aspx (cited 2025 Jun 26).&#13;
	Casellas F Dr, Arenas JI, Baudet JS, Fand;aacute;bregas S, Garcand;iacute;a N, Gelabert J, and al. Impairment of Health-Related Quality of Life in Patients With Inflammatory Bowel Disease: a Spanish Multicenter Study. Inflammatory Bowel Diseases. 2005 May 1;11(5):488?96.&#13;
	Moradkhani A, Beckman LJ, Tabibian JH. Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors. Journal of Crohn’s and Colitis. 2013 July;7(6):467?73.&#13;
	Lomer MCE. Dietary and nutritional considerations for inflammatory bowel disease. Proc Nutr Soc. 2011 Aug;70(3):329?35.&#13;
	Simrand;eacute;n M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjand;ouml;rnsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002 Feb;97(2):389?96.&#13;
	Glise H, Wiklund I. Health?related quality of life and gastrointestinal disease. J of Gastro and Hepatol (Internet). 2002 Feb (cited on June 21;2025);17(s1). available at: https://onlinelibrary.wiley.com/doi/10.1046/j.1440-1746.17.s1.6.x&#13;
	Varni JW, Shulman RJ, Self MM, Saeed SA, Patel AS, Nurko S, and al. Gastrointestinal Symptoms Predictors of Health-Related Quality of Life in Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):e186?92.&#13;
	Day AS, Yao CK, Costello SP, Andrews JM, Bryant RV. Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: A systematic scoping review. Appetite. 2021; 167:105650.&#13;
	Larussa T, Suraci E, Marasco R, Imeneo M, Abenavoli L, Luzza F. Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization. Medicina. 2019 Aug;55(8):507.&#13;
	Casellas F, Land;oacute;pez-Vivancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res. 2002; 11(8):775?81.&#13;
	Sainsbury A, Heatley RV. Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005 Mar 1;21(5):499?508.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>